Bioinformatics for T-Cell immunology-Introduction to machine and deep learning analysis- Part 5

The presetationwill cover the definitions of ‘Open Data’, ‘Entrepreneurship’ and ‘Translational Research’ and discuss how these are interlinked. Open Data is a key component for the private sector and the translation of research into ‘products’ that benefit mankind.

Learning outcome
By the end of this session you will be able to:

• Recognise the importance of Open Data to the private sector.
• Identify key characteristics of an entrepreneur.
• Identify the challenges and risks involved in developing a new therapeutic.
• Discover examples of genomics based startups and public private partnerships.
• Find more about what the Wellcome Genome Campus is doing to promote entrepreneurship.

Matthew Hall – EMBL-EBI

Matt is a Senior Scientific Officer in the Industry Partnerships team at EMBL’s European Bioinformatics Institute (EMBL-EBI). The team is responsible for overall strategy development, planning and partnership activities within EMBL-EBI. This includes development of research-related activities with industry, as well as delivery of EMBL-EBI’s Industry Programme. Matt has primary responsibility for the day-to-day management of the Industry Programme. Prior to joining EMBL-EBI, Matt had a 25-year career in the pharmaceutical industry as a bioinformatician, clinical scientist, and molecular biologist. Matt held various scientific management and leadership roles, primarily in the Bioinformatics and Computational Biology departments at GSK. He gained experience as a Clinical Director in GSK’s Africa NCD Open Lab. Matt started his career in industry with Parke-Davis/Pfizer in 1993.